Market open

Aeglea BioTherapeutics, Inc./$SYRE

Spyre Therapeutics shares are trading higher after the company reported its Q1 2025 financial results and provided a corporate update.
3 hours ago·Lightyear AI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Aeglea BioTherapeutics, Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Ticker

$SYRE
Trading on

Industry

Biotechnology

Employees

65

ISIN

US00773J2024

SYRE Metrics

BasicAdvanced
$775M
-
-$3.18
3.06
-
$775M
3.06
$21.03
$10.91
733K
11.256
11.156
-27.43%
-59.28%
2.14
2.14
-3.842
-76.88%
-49.72%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $SYRE

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Aeglea BioTherapeutics, Inc. stock?

What is the P/E ratio for Aeglea BioTherapeutics, Inc. stock?

Does Aeglea BioTherapeutics, Inc. stock pay dividends?

When is the next Aeglea BioTherapeutics, Inc. dividend payment date?

What is the beta indicator for Aeglea BioTherapeutics, Inc.?